Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BPNT2 pseudogene 1 is a genomic DNA sequence that is highly similar to the functional BPNT2 gene but does not produce a functional protein product. The functional BPNT2 gene encodes an enzyme that catalyzes the hydrolysis of phosphoadenosine phosphate to adenosine monophosphate and is involved in glycosaminoglycan sulfation, particularly in cartilage and bone development. However, the BPNT2 pseudogene 1 (BPNT2P1) is classified as a pseudogene and does not participate in these biochemical or physiological roles[1][2][4][5]. Key rationale: - BPNT2 pseudogene 1 is specifically annotated as a *pseudogene* and not a protein-coding gene[1][4][5]. - As a pseudogene, it does not possess catalytic activity nor recognized biological or disease functions. - There is no evidence in public databases or scientific literature indicating that BPNT2P1 produces a functional protein or acts as a therapeutic target. - The *functional* BPNT2 gene (not its pseudogene) is the entity associated with biological activity, disease relevance, and possible drug interactions[1][2][4]. - If your interest is in the functional protein, search for BPNT2, not BPNT2P1. Conclusion: BPNT2 pseudogene 1 (BPNT2P1) is not a valid molecular drug target. It does **not** encode a functional receptor, enzyme, or transporter, and there is nothing indicating therapeutic, biological, or biomarker relevance for BPNT2P1 itself. The correct therapeutic target is *BPNT2* (3'(2'),5'-bisphosphate nucleotidase 2), but not its pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BPNT2 pseudogene 1 (BPNT2P1).